13G Filing: Aisling Capital IV, LP and GTx Inc (GTXI)

Page 2 of 11

Page 2 of 11 – SEC Filing

CUSIP No. 40052B 20 7
SCHEDULE 13G
Page 2 of 12
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aisling Capital IV, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b) 
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON
WITH
5
SOLE VOTING POWER
1,356,697
6
SHARED VOTING POWER
0
7
SOLE DISPOSITIVE POWER
1,356,697
8
SHARED DISPOSITIVE POWER
0
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,356,697 (See Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.2%
12
TYPE OF REPORTING PERSON
PN

Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)

Page 2 of 11